Centre proposes tighter curbs on advertising of prescription drugs

Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription

The Union Health Ministry has proposed extending restrictions on advertisements of prescription medicines to drug retailers, wholesalers and distributors, seeking to close a regulatory gap in the Drugs Rules, 1945.

A draft amendment notified through Gazette notification G.S.R. 861(E) on September 28 proposes inserting a new sub-rule under Rule 65 to prohibit holders of licences to sell, stock, exhibit, offer for sale or distribute drugs listed under Schedules H, H1 and X from advertising these medicines without prior sanction of the Central government.

Under the existing framework, pharmaceutical manufacturers are prohibited from advertising drugs covered under these schedules without prior government approval. However, the corresponding restriction does not explicitly cover entities involved in the retail and wholesale sale and distribution of medicines.

The proposed amendment seeks to extend the requirement across the drug supply chain, strengthening oversight of the promotion of prescription medicines and reducing the risk of inappropriate self-medication.

The medicines covered by these schedules include drugs that require medical supervision, including certain antibiotics and psychotropic medicines. Unauthorised promotion of such medicines can encourage their use without appropriate medical advice, raising concerns over patient safety and the misuse of prescription drugs.

The proposal follows recommendations made at the 93rd meeting of the Drugs Technical Advisory Board (DTAB) on February 16, 2026, which examined the need for provisions regulating advertisements by holders of drug sale and distribution licences.

The Ministry has invited objections and suggestions from stakeholders and members of the public within 30 days of the date on which copies of the Gazette notification containing the draft rules are made available to the public.

The submissions received within the prescribed period will be considered by the Central government before the amendment is finalised.

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.